Long-term therapy of chronic delta hepatitis with peginterferon alfa-Reference-Cited by-同舟云学术

Long-term therapy of chronic delta hepatitis with peginterferon alfa

Published:2014-05-11 Issue:1 Volume:40 Page:93-104
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Heller T.¹,Rotman Y.¹,Koh C.¹,Clark S.¹,Haynes-Williams V.¹,Chang R.²,McBurney R.²,Schmid P.³,Albrecht J.³,Kleiner D. E.⁴,Ghany M. G.¹,Liang T. J.¹,Hoofnagle J. H.¹

Affiliation:

1. Liver Diseases Branch; National Institute of Diabetes & Digestive & Kidney Diseases; National Institutes of Health; Bethesda MD USA

2. Clinical Center; National Institutes of Health; Bethesda MD USA

3. National Genetics Institute; Los Angeles CA USA

4. Laboratory of Pathology; National Cancer Institute; National Institutes of Health; Bethesda MD USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12788/fullpdf

Reference42 articles.

1. Hepatitis delta virus;Hughes;Lancet,2011

2. Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA;Gudima;J Virol,2002

3. Use of a prenylation inhibitor as a novel antiviral agent;Glenn;J Virol,1998

4. Hepatitis D: thirty years after;Rizzetto;J Hepatol,2009

5. Hepatitis delta virus as a global health problem;Rizzetto;Vaccine,1990

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta;Journal of Hepatology;2024-08

2. Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide;JHEP Reports;2024-08

3. Hepatitis delta: recent advances and future therapies;Future Virology;2024-03-23

4. Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies;Current Hepatology Reports;2024-02-01

5. Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations;JHEP Reports;2024-02